Neck and tongue nerve stimulation in obstructive sleep apnea
Tests neck and tongue nerve stimulation in obstructive sleep apnea.
Key facts
- Who runs it
- Vanderbilt University Medical Center
- Where
- Nashville, United StatesSee the site
- Trial code
- Registry title
- Ansa Cervicalis and Hypoglossal Nerve Stimulation in OSA
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 3 Nov 2022
- Expected to end
- 30 Nov 2027
- Type of study
- Interventional
- Treatments tested
- Grass S88 Muscle Stimulator
- Record updated
- 29 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with obstructive sleep apnea, where the airway closes during sleep. It tests stimulating neck and tongue nerves during sleep studies.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Obstructive sleep apnea with an AHI between 20 and 80 events/hr, with at least 80% obstructive events. BMI between 25 and 40 kg/m2.
- Earlier treatment
- People who had upper airway reconstructive surgery cannot join, but past tonsil removal is allowed.
Main reasons for not taking part
- Long-term opiate use, illegal drug use or alcohol dependency
- Another sleep disorder, such as central sleep apnea, periodic limb movements or narcolepsy
- Heart or lung disease or oxygen use, or liver, kidney, immune or neurodegenerative disease
- Past bad reactions to anesthesia
- An implanted nerve stimulator, such as a cardiac pacemaker or hypoglossal nerve stimulator
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Consenting adults with BMI≥ 25 and ≤ 40 kg/m2
- Obstructive sleep apnea with an AHI between 20 and 80 events/hr (with hypopneas defined by 4% oxyhemoglobin desaturations); ≥80% obstructive events
Who cannot take part
- Chronic use of opiate medications, illicit drug use, or alcohol dependency
- Other known concomitant sleep disorder (e.g., central sleep apnea, periodic limb movements, narcolepsy)
- Clinical history or evidence of cardiopulmonary disease (or oxygen use), liver, renal, immunodeficiency, neurodegenerative diseases, or previous adverse reactions to anesthesia
- Prior upper airway reconstructive surgery excluding tonsillectomy (e.g., cleft palate repair, uvulopalatopharyngoplasty)
- Indwelling neurostimulation device (e.g. cardiac pacemaker, spinal, vagal, or hypoglossal nerve stimulator)
Where in United States
- Vanderbilt University Medical CenterNashville, United StatesContact: Katie Estes-Hartley, RPSGTTaking people
About the trial
What the trial wants to find out
Polysomnography (PSG) and drug-induced sleep endoscopy (DISE) are widely used diagnostic studies for assessing obstructive sleep apnea (OSA) severity and collapse patterns of the upper airway anatomy during sleep. Hypoglossal nerve stimulation (HNS) therapy for obstructive sleep apnea suffers from variable response at the level of the soft palate. The Investigators propose a study examining the physiologic effect of ansa cervicalis stimulation (ACS) alone and in combination with HNS during PSG and DISE.
The group in the trial
- Muscle stimulationTreatment being tested
Consented participants who meet eligibility will have a drug induced sleep endoscopy (DISE) and second sleep study and the Grass S88 (or comparable) muscle stimulator.
Treatment: Grass S88 Muscle Stimulator
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Ansa Cervicalis and Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea
- Plain-language title
- Neck and tongue nerve stimulation in obstructive sleep apneaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 29 June 2026